chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report was received from a health care professional on 12/27/01 concerning a 58 year old female patient who experienced cerebral thrombosis, which led to hospitalization, within 48 hours of receiving Fluvirin on 10/18/01 or 10/19/01. The patient had a hysterectomy in 1998, has been diagnosed for years with osteoarthritis of the right knee, has had menopause diagnosed for years, and was diagnosed within the last year with glaucoma. The patient takes Conjugated Estrogens for menopause, and Fluticasone Propionate and Loratadine for allergy. The patient received a flu vaccine of unknown source on 11/5/99 without incidence. On 10/18/01 or 10/19/01, the patient received a Fluvirin vaccine on her deltoid muscle. Within 48 hours (10/20/01), the patient was diagnosed with a cerebral thrombosis and was admitted to a hospital. The patient experienced cerebral thrombosis, MCA with right hemiparesis, and aneurysm on the left carotid artery. The patient was discharged on 10/29/01 and at the time of the report was undergoing rehabilitation therapy. The reporter has stated that the patient's family doctor believed that there was a probable relationship with Fluvirin. The patient did not have a risk factor for stroke per her family physician.
Developed a rash on both arms, actually a larger patch on the arm that did NOT receive the vaccine. Rash NOT near injection site. Because it was so odd, I looked it up on CDC site and it is similar to rash for those getting the inflammatory syndrome (dermatitis pictures). Not hot or hard, sometimes itchy, and it has been appearing and going away again over the last 2 weeks. There is no other obvious explanation as I have not been exposed to anything, and I have never had this in the past.  I think this is important for you to know as I think in the long run more will be learned about how the shot is affecting our immune systems, etc.
did not get second dose in the time period stipulated for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not get second dose in the time period stipulated for the second dose) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get second dose in the time period stipulated for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not get second dose in the time period stipulated for the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was provided by the reporter.
Patient passed out approximately 5 mins after flu hosts was administered. Called 911 -EMS said his BP was low - they gave pt. oxygen - kept him in ambulance for approximately 20-30 mins and then he came back in store to say he was feeling better.
PATIENT REPORTS LEFT ARM C-5 DERMATOME PARESTHESIA's AFTER INJECTION INTO LEFT DELTOID WITH 1st HAVRIX (LOT# AHAVB672AA ) & 2nd ENGERIX-B (LOT # AHBVCO64BB ) VACCINATIONS.
Arm pain within the hour. Fever, chills and body aches started 12 hours later Nausea the next morning, about 18 hours after shot.
Severe localized pain and swelling that progressed to whole arm pain x 1 week - hot and burning - fever 102+, fatigue.
It started as a rash 6" x 3" with some swelling, it was very hot. By the next day it was 10" x 4" and hot and swelling more. By the 3rd day, the worst, it was from my elbow to my shoulder; more swollen, more hot and went 3'4s up my arm. I went to the Pharmacist and sought their opinion. It got worse for 3 days, with day 3 being the worst. Day 4 it was better. Today is day 7 and it's much much paler but still swollen and occasionally itchy but definitely improved.  I've had rashes with the other 3 COVID-19 vaccines but this was significantly different and worse because it kept me from doing my daily activities.
Generalized pruritic rash status post small pox immunization.  Dx at the ER as vaccinia. 01/08/10. PCP records for DOS 10/26/09, 10/30/09. ER F/U visits for persistent generalized pruritic rash, onset 2 days post vaccinations. DX: vaccinia, viral exanthem
Injection site is inflammed, red and sore.  She reported having difficulty with movement with the right arm and cannot lift her arm
Case number PHEH2013US025312 is an initial spontaneous report received from a pharmacist on 04 Dec 2013. This report refers to a 14-year-old female patient. She was vaccinated with FLUCELVAX (batch number: unknown) intramuscularly on 04 Dec 2013. No adverse event was reported following medication error. Following an internal review on 18 Aug 2014, a significant correction was done for the information received on 04 Dec 2013. The labeling of the event "Inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "drug used in unapproved population".
Rash on neck for several months and spreading. Also rash on torso and arms for 4 days, slight itchy. Tiny bumps on arms for 4 days, no fever. Referred to health center for evaluation. Not sure rash related to immunizations.
Onset of PMDD with no history of PMDD - extreme mood swings leading up to menstruation, increased uterine cramping pain during 1st few days of period requiring OTC pain medication (ibuprofen PRN), increased bloating, spotting between periods
Client received 2nd COVID vaccine of Pfizer (Lot# EW0185 expiration 05/23/2021). RN noticed Client turn red and become flushed to the skin. RN provided supplemental nutrition and fluids. Client accepted. At 1740 RN and PHN responded to this event. At 1741, vital signs are blood pressure 150/90, heart rate 100, oxygen saturation 96%. Client reports anxiety, no dizziness, no headache, no blurred vision, no chest pain. Client reports history of hypertension, takes blood pressure medication every morning (today's morning dose was administered via self at home), takes over the counter aspirin as needed, and no known allergies. At 1745, vital signs are blood pressure 144/88, heart rate 101, oxygen saturation 95%. Client reports no complaints with the 1st dose. Per Client had a very stressful day. The flush reaction of the face happened within 2 minutes of administration. RN educated Client in regards to ED precautions and common adverse effects of COVID vaccine. At 1750, vital signs are blood pressure 140/88, heart rate 90, oxygen saturation 98. Client reports symptoms have resolved and skin tone returned to appropriate coloration to ethnicity. At 1800, vita signs are blood pressure 130/88, heart rate 92, oxygen saturation 97%. At 1801, Client stood up with no complaints. At 1802, Client walked out of facility with a steady gait.
Skin swollen, hard, painful to the touch in a 2 in radius around the injection site.
This spontaneous report has been received from a nurse via a field employee refers to a 16 year old male patient. In approximately June 2014 (About two months ago) the patient was vaccinated with a dose of GARDASIL (dose, strength, lot number and exp date were unknown). During the same visit, patient also received VARIVAX (Merck), VAQTA, MENACTRA (manufacturer not specified) and two other unspecified vaccinations (manufacturer not specified). The nurse reported the patient experienced seizure like symptoms and fainted after receiving the GARDASIL vaccination immediately (in approximately June 2014). Patient sought unspecified medical attention and no treatment was given no treatment for AEs. Blood test was performed but result was unknown. Nurse also reported that patient returned for a follow-up visit (date not specified) and he was fine and no longer had symptoms. Upon internal review, seizure like symptoms was considered to be medically significant. Additional information is not expected.
Chills on 10/3. Arm started getting warm with chills 10/4. Cellulitis dx on 10/5.
VACCINE SHOULD HAVE BEEN VAXELIS (DTAP/IPV/HEPB/HIB).  STAFF GAVE DTAP-IPV.
patient reports having severe pain in arm,shoulder, and neck for 2 weeks called today at 1:00pm 4/11/2022
Couldn't eat; Arm was itchy; Dizzy; Nauseous; Fever; Arm was itchy and a bit sore; This spontaneous case was reported by a patient and describes the occurrence of FEEDING DISORDER (Couldn't eat), PRURITUS (Arm was itchy), DIZZINESS (Dizzy), NAUSEA (Nauseous) and PYREXIA (Fever) in a 55-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient did not had any allergies to any food or medications.    On 08-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced FEEDING DISORDER (Couldn't eat), PRURITUS (Arm was itchy), DIZZINESS (Dizzy), NAUSEA (Nauseous), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm was itchy and a bit sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (Couldn't eat), PRURITUS (Arm was itchy), NAUSEA (Nauseous), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm was itchy and a bit sore) was resolving and DIZZINESS (Dizzy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Sep-2022, SARS-CoV-2 test: (Negative) Negative.  No concomitant medications were reported.  Patient received first dose on 26-Aug-2021 lot number 036A21A, second dose on 25-Sep-2021 lot number 038B21A, first booster dose on 05-Dec-2021 lot number 011F21A and second booster dose on 04-Apr-2022.  It was reported that the patient had a whole roster of symptoms that seemed like the coronavirus or booster side effects. It took a long time. Patient wanted to know if that was something that usually happen. Reportedly, the patient stated that the symptoms had improved. Patient felt better on that day 21-Sep-2022.   This case was linked to MOD-2022-648677 (Patient Link).
Pt received his 2nd vaccine on 4/10/21. he reported that after that he began to experience intermittent palpitations which came and went  before they persisted with associated near syncope prompting him to come to the emergency room on 6/1/21 where he was diagnosed and admitted with new onset rapid atrial fibrillation. He has no history of sleep apnea, does not drink alcohol, his tsh was normal, troponins were normal, cardiac crp was normal, d dimer was neg and PE was ruled out. he was started on metoprolol and eliquis and broke to sinus rhythm. echo was normal with no atrial enlargement and normal ejection fraction, no valvular disease, chest x ray normal, cmp and cbc normal. He was discharged home on 6/2/21. He will need follow up with cardiology.
Arm pain, extreme fatigue - sleeping, sweating/clammy, headache, nausea, loss of appetite, mild shortness of breath upon exertion like climbing stairs.
Pt fell out of his chair landing on the right side of  his body.  Unresponsive 2-3 seconds.  He was able to respond verbally immediately p initial unresponsive episode asking "how long was I out for?"   Pt is alert and oriented to person, place time situation "highlight headed.  He did not eat breakfast. 0935AM HR 67, SpO2 98%, RR 22, BP 152/94.  At 1950 AM HR 84, SpO2 97%, RR 22, BP 136/84.  At 1015AM 8 oz water, granola bar snack, Capri-sun, consumed and he felt better.  No injuries noted from falling out of chair.  At 1026AM called -made it to work.
Skin bumps on right lower side of cheek, right side of neck, and under chin.
after 5 minutes states her fingers felt weird -numb and felt like her hear was racing, very anxious started to hyperventilate. Took her to ER via WC . During transfer stated her fingers were twisting (noticed definite contractures in both hands. States her heart was beating very fast. Denies any allergies but did states she has history of low potassium and has had issues with medications nad vaccines in the past.  However no sx like this but does get "a little loopy" even when taking motrin. Instructed her to notify any provider prior to any vaccinations of the above sx. If I would have know any off this I would have highly recommended her to get authorization from her PCP prior
15 mins post vaccination pt reported dizziness. Vitals: 11:00 169/110, 104, 18, 100% -- > 11:30 180/110, 18, 100% Pt made comfortable and drank 2 bottles of water. Patient states that she does have episode of high BP after getting Ist dose of Covid vaccine. Patient states that she does have h/o high BP at home but do not want to take any medication for high BP. Denies blurred vision. Denies chest pain. Denies radiating pain to upper extremities. Patient has PMH of Preeclampsia. Advised the patient to go to the ER at facility but patient refused. Patient left AMA but dizziness better by the time she left the facility. Patient was given the number of valley connections to schedule an appointment to see her PCP for Hypertension. Pt left AMA at 11:30.  Pt reports dizziness is better and refuses to go to the ER.  AMA forms signed.
The day after the shot, my upper arm started itching(around the area where I got the shot).  It got more itchy, so I went to the clinic to get checked out.  It was red and had some inflamation.
Information has been received from a nurse referring to unspecified amount of patients of unknown age and gender. The patients' medical history, concomitant therapy and drug reactions were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # M010671, expiration date 02-JUN-2018, dose and route were not provided), which were exposed to 50 Fahrenheit (F) for 40 minutes. Previous temperature excursion: 50.2 F for 1 hour and 10 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Lot number M011671 is an invalid lot number for hepatitis b vaccine (recombinant). Additional information has been requested.
Initial report received from healthcare professional on 21 JUNE 2013. A 44-year-old female patient who had hives prior to vaccination on an unspecified date with no known drug allergies had received an intramuscular dose one of IMOVAX in left deltoid (batch number H1258) and RIG dose one from other manufacturer (Talecris) in right glut (lot number 26NL431, route of vaccination; not reported) on 10 MAY 2013 at 22:45. The concomitant medications were not reported. The patient had no illness at time of vaccination. The patient had not received any vaccines within 4 weeks of IMOVAX and RIG administration. On 11 MAY 2013, 8 hours after vaccination, the patient experienced hives which lasted for couple of days, waxing and waning. The patient had received Benadryl as corrective treatment and laboratory test were not reported. At the time of this report, the patient recovered from adverse events on an unspecified date. Documents held by sender: none.  Follow up information received from a healthcare professional on 12 AUGUST 2013. The adverse event of hives was not reported previously. The patient had history of hives with prior vaccination. IT was reported that the frequent hives was unrelated to the prior vaccination.
backache; This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (backache) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (backache). At the time of the report, BACK PAIN (backache) outcome was unknown.            No concomitant information provided The patient stated she got a vaccination this morning 3-Nov-2022 and she was fine. She was told she could take a Tylenol.  But she wanted to know if she could take Advil for back ache. No further information provided.  No treatment information provided
headache; muscle pain in the neck and back; cough; sneezing; dizziness; This is a spontaneous report from a contactable Nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient got first dose of the vaccine this Saturday and is experiencing headache and muscle pain in the neck and back (main concerns), as well as cough, sneezing (starting to go away), and dizziness; all on Jan2021. She wants to know how long these will last. She was wondering if she can take Tylenol for these symptoms. Event outcome of sneezing was recovering, while for others was unknown.  Information on the lot/batch number has been requested.
Presented to EC via EMS from an ECF for shortness of breath & hypoxia on 04/29/21.  Discharged back to facility on 05/07/21.
This spontaneous report was received from a registered nurse concerning an unspecified number of unspecified patients who on unknown dates might have received improperly stored dose of RECOMBIVAX HB (dose, route and lot # not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected.
My left shoulder started immediately after the Covid shot. I understood this might happen, so I iced it and hoped it would get better. It never got better. In fact, it only got worse, and now I have limited motion in my shoulder and pain when I sleep.
redness; itchiness; rash under the neck; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PRURITUS (itchiness) and RASH (rash under the neck) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023MDUA) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included AMLODIPINE and LOSARTAN for Hypertension.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ERYTHEMA (redness), PRURITUS (itchiness) and RASH (rash under the neck). At the time of the report, ERYTHEMA (redness), PRURITUS (itchiness) and RASH (rash under the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sudden strong swelling of lips chin and lover cheeks, mild fever. This was severe and first allergic reaction for me ever. No swelling of tongue throat or larynx. No difficulties to breath. I had cortisone pills home left over  two years earlier after prolonged resp infection.
DAD CALLED THE OFFICE ON 8/2/21 STATING THAT CHILD HAD A RAISED  ITCHY RASH ON FACE AND BODY. PATIENT/PARENT DENIES ANY CHANGES IN DIET, ENVIRONMENT, DETERGENTS ETC. PATIENT HAD TRIED ON NEW CLOTHING AT STORE THIS DAY HOWEVER CHILD INSIST THAT THE ITCHING STARTED BEFORE GOING TO STORE.  CHILD HAD RECEIVED HER FIRST DOSE OF COVID 5 DAYS EARLIER SO DAD THOUGHT THAT THIS WAS A REACTION TO THE VACCINE. DAD WANTED TO KNOW IF THE 2ND DOSE SHOULD BE GIVEN. MATTER DISCUSSED WITH DR. WHO DID NOT FEEL THAT THE RASH WAS RELATED TO THE VACCINE AND ADVISED THAT THE 2ND VACCINE BE GIVEN IN OFFICE UNDER A PROVIDER'S SCHEDULED IN LIEU OF A NURSE VISIT AS DONE FOR 1S DOSE. SECOND DOSE GIVEN ON 8/16/21 WITHOUT ANY CONCERNS.
pt recvd vax & exp pruritus w/urticaria on abdo area to rt lumbar region; pt examined by cardiologist & tx benadryl; pt exp also flu-like symptoms w/ fever, chills & arthralgia;
Within < 1 minute, post vax, pt had total body flushing without other symptoms. Rx'd Benadryl po and resolved.
Pt recvd 3 doses of Engerix-B vax on 21MAR91, 18APR91 & 17SEP91 & 29OCT91 titers were checked & a value of 1.2 was obtained;
This spontaneous report as received from a physician via a company representative refers to the physician's wife a 60-year-old female patient. No information on the patient's concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On an unknown date in an approximately November 2015 (reported as "1 year ago"), the patient was vaccinated with a dose of ZOSTAVAX (dose, route of administration, anatomical location, lot # and expiry date were not reported). On an unknown date in an approximately November 2015, 4 days after receiving ZOSTAVAX, the patient developed myelitis. The outcome of myelitis was reported as fully recovered on an unknown date. The relatedness between the event of myelitis and ZOSTAVAX was not reported. Upon internal review, the event of myelitis was considered to be medically significant. Additional information is not expected because there was no consent to contact the physician.
Shoulder pain 2 days after vaccination. Patient went to doctor and doctor prescribed cortisone shot after physical exam.
Delayed nocturnal fever and chills spanning 72 hrs. Multiple bouts diarrhea despite hydration. Injection site pain 4 days.
Post-ZOSTAVAX administration; patient suffered local reaction-significant itching; local reaction approx 4 inches in diameter.
vertigo; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (Pfizer-Biontech Covid-19 vaccine), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, 14 days after vaccination, the patient experienced vertigo specially in the morning. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This case was reported by a consumer and described the occurrence of leg pain in a 5-month-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included atopic dermatitis. Concurrent vaccinations on 14 November 2011 included Haemophilus influenzae type b vaccine;manufacturer unspecified and Pneumococcal vaccine  (non-gsk);manufacturer unspecified. On 14 November 2011 at 12:00 the subject received a dose of KINRIX (unknown route, unknown thigh) as the 2nd dose of the series and experienced leg pain and wrong vaccine administered. KINRIX was given instead of PEDIARIX and the subject was younger than that indicated age for KINRIX administration. The mother did not notice anything unusual about the baby or his behavior. The baby did not have a fever and was not sick. He did have a little pain in the leg after the injection. On an unspecified date. the leg pain resolved.
Patient complained of throat closing, she was able to speak normally, no breathing difficulties.  Patient did not want to receive the EpiPen shot.  The paramedic arrived and confirmed she was having an anxiety attack.